How to Respond When the Korea Fair Trade Commission Opens a Merger Investigation After Signing an SPA

Respond korea fair trade commission opens is the search most deal teams run the moment they learn that a signed transaction has drawn antitrust scrutiny in South Korea, and the first few days after that notice usually determine how much deal certainty survives. When the Korea Fair Trade Commission (KFTC) opens a merger investigation after an SPA is signed, the parties face a compressed set of choices about whether to suspend, close under conditions, or restructure the bargain entirely.

This article explains the procedural mechanics under the Monopoly Regulation and Fair Trade Act (MRFTA), the suspend-versus-complete decision, interim measures the KFTC can impose, how to re-draft conditionality and indemnities, and how to coordinate parallel filings across the EU, US and China. Treat the illustrative clauses and timelines below as a starting framework for discussion with South Korea-qualified counsel, not as legal advice.

Immediate checklist, the first 24 to 72 hours

Before analysing the law, stabilise the deal. When you need to respond and the Korea Fair Trade Commission opens a merger investigation, counsel for both sides should move through the following actions quickly and in parallel:

• Notify deal counsel and regulatory specialists. Engage Korean competition and litigation counsel immediately; confirm who leads KFTC communications.
• Re-read the SPA. Identify the regulatory condition precedent, long-stop date, efforts standard and termination triggers before taking any position.
• Preserve documents. Issue a litigation and investigation hold covering transaction records, internal competition assessments and integration planning materials.
• Freeze integration steps. Suspend any pre-closing integration, information sharing or operational coordination that could be read as gun-jumping.
• Alert financing counterparties. Inform lenders and underwriters of the review and any impact on the funding timetable.
• Notify insurers. Trigger notice obligations under any warranty and indemnity policy to preserve coverage.
• Map parallel filings. List all other antitrust jurisdictions where the deal is notifiable and check for timing conflicts.
• Open a negotiation channel. Agree a protocol between buyer and seller for cooperation, cost-sharing and KFTC engagement.

What the opening of a KFTC investigation means for your deal

The KFTC administers merger control in South Korea under the MRFTA. When the Commission examines a transaction, the process can broadly be understood in two stages. The first is a preliminary review, in which the KFTC assesses whether the transaction raises competition concerns on the information filed. The second is an in-depth or formal review, triggered where the preliminary assessment identifies a plausible risk to competition and the Commission requires deeper analysis, additional data and often market testing.

It matters which stage you are in. A preliminary review that extends into an in-depth review signals that clearance is no longer a formality and that remedies, behavioural or structural, may be on the table. The KFTC’s published procedures and guidance explain notification requirements, the information the Commission may demand, and the powers it exercises during review. Deal teams should read the official KFTC materials rather than rely on general summaries, because the precise scope of a review shapes every downstream decision.

A crucial distinction is between pre-notification and post-signing review. Many cross-border deals are signed and then notified, so a review opening after signature is common and does not, by itself, mean the parties have done anything wrong. What changes is the risk profile: once the Commission is actively examining the transaction, the parties must manage both the regulatory process and the contractual relationship between them with far greater discipline. The MRFTA framework governs thresholds, suspensory obligations and the Commission’s enforcement toolkit, and the authoritative English statutory text is available through the Korea Law Information Center.

Respond when the Korea Fair Trade Commission opens: suspend versus complete

The central decision after a review opens is whether to pause closing or to proceed under conditions. There is no single correct answer, it depends on the SPA wording, the KFTC’s posture, and each party’s commercial tolerance for risk. Understanding how legal and contractual suspension interact is essential to deciding how to respond when the Korea Fair Trade Commission opens a merger investigation.

Legal suspension versus contractual suspension

Two separate mechanisms can hold up a closing. The first is any statutory suspensory obligation or Commission order under the MRFTA that restricts completing integration steps before clearance in certain circumstances. The second is contractual: a condition precedent in the SPA that makes closing conditional on KFTC clearance. These are not the same. An SPA that is silent on regulatory clearance, or that imposes only a weak “best efforts” obligation, may not give either party a clean right to delay, the contractual effect is controlled by the words on the page. Where the SPA contains a robust clearance condition precedent, the parties generally cannot close until the condition is satisfied or waived.

Completing under conditions, undertakings and mitigation

Where the parties want deal momentum, several structures allow a conditional path forward. These include holdbacks and escrow arrangements to cover remedy or penalty exposure, closing subject to behavioural undertakings offered to the KFTC, and structured or deferred closings that stage integration until clearance arrives. Each carries enforcement risk: completing core integration without the required clearance can expose the parties to KFTC action and penalties, so any “close now” structure must be designed with Korean counsel to avoid gun-jumping.

Comparison table, suspend versus complete

KFTC powers, interim measures and likely remedies

During a merger review the KFTC exercises substantial authority under the MRFTA. The Commission can require the parties to provide information and documents, can take steps to prevent conduct that would prejudge or frustrate its review, and can ultimately impose remedies as a condition of clearance. These remedies fall into two broad categories: behavioural commitments, such as access, supply or firewall obligations, and structural remedies, such as divestitures of overlapping assets or businesses.

Where the Commission is concerned that integration would cause harm to competition before it can complete its analysis, it may use corrective measures to address that risk. The practical effect is that buyers must be cautious about any conduct that integrates the target or removes it as an independent competitive force before clearance. Completing a transaction, or material integration steps, without the required clearance can expose the parties to enforcement and penalties under the MRFTA. For the precise scope of the Commission’s powers and the conditions attached to any intervention, counsel should consult the official KFTC guidance and the statutory provisions.

Timelines for intervention are driven by competitive urgency rather than a fixed calendar. Where the KFTC perceives a real risk of harm, it can act promptly. Deal teams should therefore assume that any aggressive integration during a live review invites scrutiny, and should document a clear separation between the signed parties until clearance is obtained.

Immediate practical steps for buyers and sellers

Beyond the first-72-hour triage, counsel should operationalise a disciplined response. The following checklist assigns actions and owners so that nothing falls between buyer and seller teams while they respond and the Korea Fair Trade Commission opens its substantive assessment:

• Internal communications protocol. Legal leads should control messaging; brief executives on what can and cannot be shared across the two businesses.
• Document preservation. Compliance owners must confirm the hold is live and that no transaction materials are deleted or altered.
• Financing coordination. Treasury and deal counsel should confirm the impact on commitment letters and any flex or extension mechanics.
• Escrow activation. If the SPA contemplates escrow for regulatory risk, confirm the trigger conditions and funding mechanics now, not at closing.
• Insurer notification. Risk managers should notify warranty and indemnity insurers promptly to preserve coverage and avoid late-notice disputes.
• Parallel-authority coordination. Competition counsel should align the KFTC response with any EU, US, UK or China filings to prevent inconsistent positions.
• Negotiation mandate. Principals should agree the commercial parameters for any SPA amendment before counsel begin redlining.

Renegotiating and re-drafting the SPA, conditionality, indemnity and termination

Once a review is live, the signed SPA may no longer reflect the parties’ real risk allocation. Renegotiation is common, and the leverage shifts depending on each side’s appetite to walk away. Counsel should approach the amendment methodically, working through conditionality, efforts standards, indemnities, termination and price.

Reframing the condition precedent and efforts standard

The clearance condition precedent should specify the standard of clearance required, for example, unconditional clearance versus clearance subject to acceptable remedies, and should define how far each party must go to obtain it. The efforts standard is often the most contested point. A “best efforts” or “hell or high water” obligation can require the buyer to accept divestitures, while a “reasonable efforts” standard caps the burden. The parties should also revisit the long-stop date to ensure it accommodates a realistic KFTC review timetable rather than an optimistic pre-signing assumption.

Indemnity triggers, termination rights and break fees

Where regulatory failure is a live risk, the SPA should say clearly who bears the consequences. Options include an indemnity triggered by remedy costs or penalties, a termination right exercisable at the long-stop if clearance is not obtained, and a reverse break fee payable by the buyer if the deal fails for regulatory reasons. Price adjustment and escrow structures can absorb the cost of remedies the KFTC requires, so that a divestiture mandated as a clearance condition does not fall entirely on one party.

Sample indemnity and termination clause options (illustrative only)

The following drafting outlines are illustrative only. They are not clause-ready and must be reviewed and adapted by a South Korea-qualified lawyer before use:

• Buyer-favourable regulatory indemnity. A provision under which the seller indemnifies the buyer for defined losses arising from KFTC-imposed remedies or penalties up to an agreed cap, with an escrow securing the exposure until clearance.
• Seller-favourable efforts and termination clause. A provision requiring the buyer to use broad efforts to secure clearance, including accepting proportionate remedies, and entitling the seller to a reverse break fee if the buyer declines a remedy that would have unlocked clearance.
• Neutral long-stop and allocation clause. A balanced provision setting a realistic long-stop date, a mutual termination right if clearance is not obtained by that date, and a pre-agreed split of remedy costs below a stated threshold with escalation above it.

Because clause language generated by drafting tools is illustrative at best, every term, and especially any efforts standard, cap or trigger, must be validated against the MRFTA, current KFTC guidance and precedent, and tailored to the specific transaction by qualified counsel.

Coordinating multi-jurisdictional filings and parallel reviews

Most transactions large enough to attract a KFTC review are notifiable elsewhere. Synchronising South Korea with the EU, UK, US and China is a discipline in its own right, and mismatched timing or inconsistent submissions can create avoidable problems. The OECD’s work on merger control offers useful comparative context for why coordinated review strategies matter and how authorities approach remedies.

Several practical principles guide coordination. First, identify which authority is likely to set the toughest remedies and sequence engagement so that remedy design in one jurisdiction does not undercut your position in another. Second, manage confidentiality carefully: sharing information between authorities often requires waivers, and parties should decide deliberately what to waive and when. Third, align the substance of submissions so that market definitions, theories of harm and remedy proposals are consistent across filings, inconsistencies are quickly spotted and damage credibility. Fourth, build the timetable backwards from the slowest expected clearance, because the long-stop date in the SPA must survive the critical path, not the optimistic one.

A simple way to visualise the sequencing is to plot each jurisdiction’s expected review period on a shared timeline, mark the earliest and latest realistic clearance dates, and identify where remedy decisions in one forum would feed into another. That picture tells the deal team where the binding constraints sit and where pre-notification contact can shorten the path.

Remedies and appeals, litigation strategy after an adverse KFTC finding

If the KFTC reaches an adverse conclusion or imposes remedies the parties cannot accept, the question becomes whether and how to challenge it. South Korea provides administrative and judicial routes to review Commission decisions. The practical strategy usually begins with engagement, negotiating the scope of remedies with the KFTC before any decision is finalised, because a negotiated behavioural or structural package is often preferable to a protracted appeal.

Where challenge is necessary, the parties may seek reconsideration within the KFTC process and, ultimately, pursue judicial review before the courts. In practice, appeals against KFTC decisions are heard by the Seoul High Court at first instance, with a further appeal to the Supreme Court of Korea. Timelines, the standard of review and the suspensive effect of any challenge are governed by Korean administrative procedure and court rules; the KFTC, the Ministry of Justice and the Supreme Court of Korea are the authoritative references for those processes. Litigation carries cost and duration risk, and a successful challenge is never guaranteed, so counsel should weigh the commercial value of the contested remedy against the time and expense of appeal.

In many cases the better outcome is a modified remedy agreed with the Commission rather than a win in court years later.

Allocation of regulatory risk, who pays?

The question of who bears the cost of remedies or penalties is a core negotiation. There is no default answer; the allocation reflects bargaining power, the probability and size of the exposure, and market practice. The main tools are indemnities, purchase price adjustments, escrow and insurance, and each suits a different risk profile.

Market practice frequently blends these, for example, an escrow-backed indemnity below a threshold with a termination right above it. The broader M&A process context, including thresholds and standard transaction steps, is set out in the M&A transaction South Korea: step-by-step legal guide, which is a useful companion to this playbook.

Preserving deal certainty, best practices

Deal certainty is easiest to protect when the parties plan for regulatory risk before signing and act with discipline once a review opens. The following best practices, roughly in priority order, help parties respond when the Korea Fair Trade Commission opens a merger investigation:

• Front-load the risk assessment. Assess KFTC risk before signing and reflect it in conditionality and pricing (high priority).
• Draft a realistic long-stop. Set a long-stop date that survives a genuine in-depth review (high priority).
• Define the efforts standard precisely. Avoid ambiguous “best efforts” language that invites disputes (high priority).
• Maintain separation until clearance. Keep the businesses independent and avoid gun-jumping (high priority).
• Agree a cooperation protocol. Fix lead party, cost-sharing and communication rules for all filings (medium priority).
• Coordinate parallel authorities. Align submissions and remedy proposals across jurisdictions (medium priority).
• Preserve documents rigorously. Keep a clean, defensible record from the outset (medium priority).
• Prepare contingency structures. Pre-agree escrow, holdback and break-fee mechanics so they can activate quickly (medium priority).
• Keep insurers and lenders informed. Prevent coverage and funding surprises (lower priority but easy to execute).

Conclusion, recommended next steps

When you need to respond and the Korea Fair Trade Commission opens a merger investigation after signing, the winning approach is procedural discipline paired with fast contractual decision-making. Confirm the suspensory position under the MRFTA and the SPA, avoid any integration that could be read as gun-jumping, decide between suspending and conditional completion with Korean counsel, and re-draft conditionality, indemnities and termination rights to reflect the real risk now that a review is live. Coordinate the KFTC process with every parallel filing, and keep an appeal strategy in reserve while prioritising negotiated remedies. Deal teams that move quickly on these fronts preserve the most value.

For tailored advice on how to respond when the Korea Fair Trade Commission opens a review of your transaction, and for help drafting defensible SPA protections, consult South Korea litigation and M&A counsel through Global Law Experts. This article is general information only and is not legal advice.

Sources

1. Korea Fair Trade Commission (KFTC), English
2. Korea Law Information Center (KLRI), English
3. Supreme Court of Korea, English
4. Ministry of Justice, Republic of Korea, English
5. OECD, Competition and Merger Control Resources
6. Global Law Experts, M&A Transaction South Korea: Legal Guide